Sutter Health Research Enterprise
3100 Summit Street
2nd Floor
Oakland, CA, 94609
(510) 869-8400
HallC4@sutterhealth.org
Primary Research Interests
Related Clinical Trials
D8110C00001 (Covid-19)
Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222
Investigator: Christopher Hall M.D
Status: Active, Not Recruiting